http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62255423-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-48 |
| filingDate | 1986-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10d84fddcb026c1d13f4315b7a2e400 |
| publicationDate | 1987-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S62255423-A |
| titleOfInvention | Remedy for acute damage of central nerves |
| abstract | PURPOSE: A remedy for damages of central nervous tissues caused acute wounds and circulation disorders in brain and spinal cords that contains E-64c in CAMP inhibitor as an active ingredient. n CONSTITUTION: The objective remedy contains, as an active ingredient, (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butyl-carbamoyl]-2-oxyrane-carbox ylic acid (E-4c), which is an inhibitor of CAMP (calcium-depending neutral protease) or its salt or alkyl ester. The remedy is appliedorally or parenterally (e.g., by injection) given to an adult 100W2,000mg a day in one to three portions calculated as E-64c or its alkyl ester. n COPYRIGHT: (C)1987,JPO&Japio |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9323032-A1 |
| priorityDate | 1986-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.